爱思益普可提供MAP2K4靶点筛选服务。MAP2K4采用ADP-Glo方法进行筛选。ADP-Glo是一种通过量化激酶反应期间产生的 ADP 的量来测量激酶活性的方法，也是一种通用、均相、高通量筛选的方法。该测定分两步进行：首先，在激酶反应后，加入 ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...

Immuneering Corp. Class A ( (IMRX) ) has released its Q3 earnings. Here is a breakdown of the information Immuneering Corp. Class A presented ...

Fintel reports that on November 18, 2024, Jefferies initiated coverage of Erasca (NasdaqGS:ERAS) with a Buy recommendation.

Positive preliminary Phase 1b data in SEACRAFT-1 NRASm melanoma cohort bolsters conviction in ongoing SEACRAFT-2 registrational trial; Stage 1 randomized data expected in 2025 Strong execution across ...

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, ...